FogPharma Appoints Dr. Barbara Weber to its Board of Directors

CEO of Tango Therapeutics and Venture Partner at Third Rock Ventures to lend her expertise to FogPharma as the Company continues to advance a powerful new class of medicines - cell-penetrating miniproteins - for the treatment of serious diseases

BOSTON,... Biopharmaceuticals, Personnel FogPharma, miniprotein

Source: HSMN NewsFeed - October 25, 2018 Category: Pharmaceuticals Source Type: news